Authors analyzed a large dihydroartemisinin–piperaquine (DHA-PPQ) repetitive treatment efficacy trial including a 2-year follow-up period, monitoring the evolution of the protective effect of this antimalarial over time.
- Leyre Pernaute-Lau
- Mario Recker
- José Pedro Gil
